未登录

G

Gail Geller

Johns Hopkins University

H指数:50

被引数:7,266

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

More evidence is needed to improve molecular HIV surveillance for cluster detection and response

需要更多证据来改进分子HIV监测，以进行聚集性检测和应对。

Communications Medicine

IF6.3

2025-11-140

OAAI

Clinician Perspectives on Disclosing Public Health Uses of HIV Antiretroviral Resistance Testing Results

临床医生对披露HIV抗逆转录病毒耐药性检测结果公共卫生用途的看法

jaids journal of acquired immune deficiency syndromes

IF0

2025-08-250

PRE

Achieving Greater Transparency Regarding Molecular HIV Surveillance: A Proposal to Move Beyond the Status Quo

关于分子HIV监测更大透明度的实现：一项超越现状的提案

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2025-07-011

OAAI

Patient and Physician Perspectives on Discussing Addiction Recovery and Spirituality in the Primary Care Setting

JOURNAL OF GENERAL INTERNAL MEDICINE

IF4.2

2024-07-190

PRE

Prioritization of ethical concerns regarding HIV molecular epidemiology by public health practitioners and researchers

BMC PUBLIC HEALTH

IF3.6

2024-05-291

OAAI

The ethics of using COVID-19 host genomic information for clinical and public health decision-making: A survey of US health professionals

HUMAN GENETICS AND GENOMICS ADVANCES

IF3.6

2024-01-011

OAAI

Capacity for wonder among medical students: Assessment and educational implications

MEDICAL TEACHER

IF4.4

2022-07-202

PRE

Vaccinomics: a cross-sectional survey of public values

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2021-06-211

OAAI

Development of a Scale to Measure Trust in Public Health Authorities: Prevalence of Trust and Association with Vaccination

JOURNAL OF HEALTH COMMUNICATION

IF2.4

2021-05-1631

OAAI

Ethical and policy implications of vaccinomics in the United States: community members' perspectives

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2021-02-243

OAAI

Tolerance for Uncertainty and Professional Development: a Normative Analysis

JOURNAL OF GENERAL INTERNAL MEDICINE

IF4.2

2021-02-0231

OAAI

SARS-CoV-2 safer infection sites: moral entitlement, pragmatic harm reduction strategy or ethical outrage?

SARS-CoV-2更安全的感染部位: 道德权利，务实的减少伤害策略或道德愤怒？

JOURNAL OF MEDICAL ETHICS

IF3.4

2020-12-091

PREAI

Tolerance for Ambiguity Among Medical Students: Patterns of Change During Medical School and Their Implications for Professional Development

ACADEMIC MEDICINE

IF5.2

2020-11-0339

OA

Patients' Views About the Disclosure of Collateral Findings in Pragmatic Clinical Trials: a Focus Group Study

JOURNAL OF GENERAL INTERNAL MEDICINE

IF4.2

2020-08-197

OAAI

The art of medicine Dramatic interventions in the tragedy of the COVID-19 pandemic

IF88.5

2020-08-0111

OAAI

A medical student scholarly concentrations program: scholarly self-efficacy and impact on future research activities

MEDICAL EDUCATION ONLINE

IF3.8

2020-06-2614

OAAI

What If the Influenza Vaccine Did Not Offer Such Variable Protection?

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2020-05-092

OAAI

Ethics and Collateral Findings in Pragmatic Clinical Trials

实用性临床试验中的伦理学和附带发现

AMERICAN JOURNAL OF BIOETHICS

IF20.8

2020-01-0217

OAAI

Ethical considerations in global HIV phylogenetic research

IF13

2018-11-0133

OAAI

Measuring patient respect in the intensive care unit: Validation of the ICU-RESPECT instrument

JOURNAL OF CRITICAL CARE

IF2.9

2018-08-016

PREAI